Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Lunch and Poster Display session

86P - The value of intraoperative frozen section examination in the survival of breast cancer

Date

16 May 2024

Session

Lunch and Poster Display session

Presenters

Ulrike Heber

Citation

Annals of Oncology (2024) 9 (suppl_4): 1-9. 10.1016/esmoop/esmoop103095

Authors

A.W. Zhu1, R. Ullrich2, J. Pammer2, G. Hofstetter2, E. Langthaler2, T. Helbich1, D. Kauer-Dorner2, R. Bartsch3, C.F. Singer2, Z.A. Bago-Horvath2, U.M. Heber2

Author affiliations

  • 1 Medical University Vienna, Vienna/AT
  • 2 Medical University of Vienna, Vienna/AT
  • 3 Medizinische Universitaet Wien, Vienna/AT

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 86P

Background

Frozen section (IFS) assessment enables intraoperative assessment of resection margins, however, its accuracy is subjected to interobserver variability. This study evaluated factors that affect efficacy of resection margin evaluation using IFS in a cohort of breast cancer patients and its impact on disease free and overall survival.

Methods

All patients presenting with primary operable breast carcinoma who received IFS between 2016 and 2018 at the Breast Health Centre of the Medical University Vienna were included in the study. Patients received standard adjuvant treatment as indicated by current guidelines. Data were collected retrospectively. Cox regression was used to test for a difference in survival between patients with incorrect and correct IFS.

Results

The study cohort consisted of 997 female patients with a mean age of 58.8 (± 12.9). IFS assessment was true positive in 222 cases (21.3%), false positive in 158 (15.2%), true negative in 629 (60.5%) and false negative in 31 cases (3%), translating into a sensitivity of 0.87 and a specificity of 0.8 of IFS. 152 patients (14.6%) received a follow up resection after a false positive IFS and in 5 cases (0.5%) a false negative IFS led to no follow up resection. 73 patients (7.3%) had at least 1 reoperation, with residual tumor tissue in 29 (39.7%) of these. Factors associated with incorrect IFS were intrinsic subtype luminal B HER2 negative (p<0.001), and refrainment from neoadjuvant treatment (p=0.002). Lymph node metastasis was associated with residual tumor in subsequent resection specimens (p=0.03). Correctness of IFS did not impact local recurrence (p=0.39), progression free survival (PFS; p=0.7) and overall survival (OS; p=0.17). Also, no difference was detected in true negative vs false negative IFS regarding PFS (p=0.6); but interestingly there was a difference in OS (p<0.001), in favor of patients with true negative IFS.

Conclusions

Our study shows that resection margin assessment using IFS does not affect local recurrence or progression free survival of breast cancer patients, regardless of its correctness. The results of our study indicate that intrinsic subtype has an impact on resection margin assessment and extended local surgery might not ameliorate adverse prognosis despite negative margins.

Legal entity responsible for the study

The authors.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.